COMMERCIALISATION PILOT

The purpose of this scheme is to provide support to enable successful applicants to work with a Partner based in an appropriate company/industry to move their research towards use or commercialisation.

Translational funding is available for projects up to a maximum of £85,000, that must be completed no later than 1 June 2022. This funding is for Directly Incurred (DI) Costs, and additional 20% of your budget can be requested as a contribution towards DA/Indirect Costs.

Eligibility: To be eligible for funding you must:

• be a researcher based at a Bloomsbury SET academic institution (London School of Hygiene and Tropical Medicine, Liverpool School of Tropical Medicine, the Royal Veterinary College, and SOAS, University of London)
• have a potentially commercialisable project related to infectious disease, NTDs, or AMR, at a minimum Technology Readiness Level 3 (see guidance for TRL detail)
• be committed to progressing your project closer to commercialisation
• have the support of your institution’s technology transfer office, or equivalent appropriate team

The funding must be used to progress translational R & D at one of the member institutions listed above through one or more Technology Readiness Levels (TRLs) towards commercialisation (see guidance notes).

APPLICATIONS ARE NOW CLOSED

Local research office contacts are:

• LSHTM: Alex Anderson
• LSTM: Sarah Roberts
• RVC: Emma Tomlinson or Ray Kent
• SOAS: Jessica Pavlos